FQ MEDIKAZIOAK

VERTEXEK EUROPAREN BAIMENA LORVETU DU ORKAMBI MEDIKAMENTUA KOMERTZIALIZATZEKO

VERTEXEK EUROPAREN BAIMENA LORTU DU ORKAMBI MEDIKAMENTUA KOMERTZIALIZATZEKO. Vertexek jakin arazi duenez, Europako Komisioak baimena eman dio ORKAMBI (lumacaftor/ivacaftor) medikamentua komertzializatzeko. F508del mutazio bikoitza duten 12 urtetik gorako pertsonetan...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.